Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Fuji
Healthtrust
Harvard Business School
Cantor Fitzgerald
QuintilesIMS
Queensland Health
Argus Health

Generated: July 16, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: remifentanil hydrochloride

« Back to Dashboard

Remifentanil

CASRN: 132875-61-7UNII:

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Dow
Baxter
Citi
Healthtrust
AstraZeneca
Federal Trade Commission
Cantor Fitzgerald
Merck